{
  "_id": "417d38a537b6f0008ecad3ea2a280eb7d6444591b6b538b47a4d097252ce7841",
  "feed": "wall-street-journal",
  "title": "Roblox, BlackBerry, Pfizer, Adagio Therapeutics: What to Watch in the Stock Market Today; Tests suggested that Pfizer's Covid-19 pill could work against Omicron; An analyst cut its rating of Adagio Therapeutics shares",
  "text": "<p>* Preliminary laboratory tests gave encouraging signs that the Pfizer's experimental Covid-19 pill for the newly infected could work against Omicron, the company said.</p><p>* Eli Lilly raised its 2021 financial guidance and set its outlook for its performance in 2022.</p><p>* Manufacturer Entegris plans to acquire CMC Materials in a cash-and-stock deal with an enterprise value of about $6.5 billion</p><p>* Goldman Sachs lifted its rating for the Host Hotels &amp; Resorts shares to neutral and nudged up the price target to $18 from $17.</p><p>* Home improvement and building product maker Masco was also the beneficiary of a ratings upgrade, from Barclays, who lifted the price target to $83 from $67.</p><p>* Regeneron Pharmaceuticals wasn't so lucky, with its shares down after Bernstein cut its rating of the stock to market perform. Adagio Therapeutics also got a ratings cut, from Stifel, who slashed the price target to $9 from $50.</p><p>* Some meme stocks were drifting lower in early trading, including AMC Entertainment and GameStop.</p><p>* However one stock that spent some time drawing attention from retail traders earlier this year, BlackBerry, was on the rise. The company said it would collaborate with BMW Group on the development of automotive technologies, and that BlackBerry was licensing some of its technology to BMW as part of the arrangement.</p><p>* Education technology company Skillsoft reported earnings and raised its full-year outlook.</p><p>* Nordson and Heico are among the companies reporting earnings Wednesday.</p><p>Chart of the Day</p><p>* Biotech stocks have crumbled this year and a number of prominent hedge funds have suffered deep losses. But some biotech investors are thriving by focusing on mergers, short selling and Covid-19 stocks.</p><p>Write to James Willhite at james.willhite@wsj.com</p><p>Roblox, BlackBerry, Pfizer, Adagio Therapeutics: What to Watch in the Stock Market Today</p>",
  "published": "2021-12-15T14:38:00.000Z",
  "tags": [
    {
      "id": "US38141G1040",
      "nexusId": "10038135",
      "name": "The Goldman Sachs Group, Inc.",
      "offsets": [
        {
          "start": 393,
          "end": 406
        },
        {
          "start": 393,
          "end": 400
        }
      ]
    }
  ]
}